pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·13h ago·1 min read
save

Siemens Healthineers teams with Paradromics to develop multimodal imaging platform for brain-computer interfaces

Oct 19, 2026·read at Fierce Biotech ↗DealPositive

Siemens Healthineers and Paradromics announced a collaboration to build an advanced multimodal imaging system designed to support implantable brain‑computer interfaces (BCIs). The partnership combines Siemens Healthineers' imaging expertise with Paradromics' clinical and technical knowledge of BCI technology.

The joint effort will create an integrated imaging workflow that covers the full spectrum of BCI care, from assessing patient eligibility and identifying neural targets to surgical planning, intra‑operative navigation, post‑implant localization, validation of functional imaging findings, and outcomes assessment.

The initiative reflects the broader shift of BCIs from academic research toward clinical applications that can restore communication and computer control for patients. The article also references ongoing clinical trials by companies such as Synchron and recent milestones achieved by Neuralink, underscoring the growing momentum in the field.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Siemens Healthineers partners with Paradromics to build out new imaging system to support BCIs”

read at Fierce Biotech ↗
489 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Diagnostics Company2Medical Device Company2

related stories

  • Aug 27Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drugFierce Biotech
  • Aug 26Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its businessFierce Biotech
  • Aug 25Roche, Eli Lilly get FDA nod for new Alzheimer’s blood testBioPharma Dive
  • Aug 25Labcorp launches new hepatitis D test to find patients with most severe form of virusFierce Biotech
  • Aug 24Qiagen appoints new chief executive after 9-month searchFierce Biotech